应对埃博拉病毒病——中国在行动
Emergency response to Ebolavirus disease: action in China

DOI: 10.6040/j.issn.1671-7554.2.2014.001

Keywords: 埃博拉病毒病,中国,埃博拉病毒,应对,
Emergency response,China,Ebolavirus disease,Ebolavirus

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	World Health Organization. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa[EB/OL].(2014-08-08)[2014-11-20]. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/.
[2]	Ascenzi P, Bocedi A, Heptonstall J, et al. Ebolavirus and Marburgvirus:insight the Filoviridae family[J]. Mol Aspects Med, 2008, 29(3): 151-185.
[3]	程颖, 刘军, 李昱, 等. 埃博拉病毒病:病原学、致病机制、治疗与疫苗研究进展[J]. 科学通报, 2014, 59(30): 2889-2899. CHENG Ying, LIU Jun, LI Yu, et al. Ebola virus disease:virology, pathogenesis, therapy, and vaccines[J]. Chin Sci Bull(Chin Ver), 2014, 59(30): 2889-2899.
[4]	Centre for Infectious Disease Research and Policy. Experimental Ebola drug may have helped 2USpatients[EB/OL].(2014-08-05)[2014-11-20].http://www.cidrap.umn.edu/news-perspective/2014/08/experimental-ebola-drug-may-have-helped-2-us-patients.
[5]	Swenson DL, Wang D, Luo M, et al. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections[J]. Clin Vaccine Immunol, 2008, 15(3): 460-467.
[6]	Centres for Disease Control and Prevention. Ebola (Ebola Virus Disease):signs and symptoms[EB/OL].(2014-08-15)[2014-11-20]. http://www.cdc.gov/vhf/ebola/symptoms/index.html.
[7]	盖微微, 郑学星, 薛向红, 等. 埃博拉病毒VP40蛋白的原核表达及其抗体间接ELISA检测方法的建立[J]. 中国病原生物学杂志, 2013, 8(9): 782-786. GAI Weiwei, ZHENG Xuexing, XUE Xianghong, et al. Expression of the VP40 gene of Ebola virus and development of recombinant protein-based indirect ELISA for antibody detection[J]. Journal of Pathogen Biology, 2013, 8(9):782-786.
[8]	盖微微,郑学星, 薛向红, 等. 埃博拉病毒检测与分型Real-time PCR方法的建立[J]. 中国病原生物学杂志, 2013, 8(3): 208-216. GAI Weiwei, ZHENG Xuexing, XUE Xianghong, et al. Development of a real-time PCR method to detect and type Ebola virus[J]. Journal of Pathogen Biology, 2013, 8(3):208-211,216.
[9]	Heinz F, Thomas WG. Ebola haemorrhagic fever[J]. Lancet, 2011, 377(9768):849-862.
[10]	Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebolavirus disease in Guinea[J]. N Engl J Med, 2014, 371:1418-1425.
[11]	Geisbert TW, Daddario-Dicaprio KM, Lewis MG, et al. Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates[J]. PLoS Pathog, 2008, 4(11):e1000225. doi: 10.1371/journal.ppat.1000225.
[12]	WHO/International Study Team. Ebola haemorrhagic fever in Sudan, 1976[J]. Bull World Health Organ, 1978, 56(2): 247-270.
[13]	World Health Organization. Ebola haemorrhagic fever in Zaire, 1976[J]. Bull World Health Organ, 1978, 56(2): 271-293.
[14]	Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats[J]. PLoS pathog, 2009, 5(7): e1000536. doi: 10.1371/journal.ppat.1000536.
[15]	Pourrut X, Kumulungui B,Wittmann T. The natural history of Ebola virus in Africa[J]. Microbes Infect, 2005, 7(7-8): 1005-1014.
[16]	Leroy M, Kumulungui B, Pourrut X. Fruit bats as reservoirs of Ebola virus [J]. Nature, 2005, 438(7068): 575-576.
[17]	王淑杰, 王喜军, 胡森, 等. 抗埃博拉病毒VP40蛋白单克隆抗体的制备及在抗原捕捉 ELISA 中的应用[J]. 中国预防兽医学报, 2008, 30(4): 309-313. WANG Shujie, WANG Xijun, HU Sen, et al. Development of an antigen capture ELISA agains t VP40 protein of Ebola virus us ing monoclonal antibodies[J]. Chinese Journal of Preventive Veterinary Medicine, 2008, 30(4): 309-313.
[18]	庞正, 李德新. 病毒性出血热实验室检测[J]. 病毒学报, 2013, 29(3): 349-356. PANG Zheng, LI Dexin. Laboratory diagnosis of viral hemorrhagic fevers[J]. Chinese Journal of Virology, 2013, 29(3): 349-356.
[19]	Yang L, Sanchez A, Ward JM, et al. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals[J]. Virology, 2008, 377(2): 255-264.
[20]	李小波, 相大鹏. 埃博拉出血热及其实验室检测研究方法[J]. 中国人兽共患病学报, 2009, 25(9): 899-901.
[21]	Piercy TJ, Smither SJ, Steward JA, et al. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol[J]. J Appl Microbiol, 2010, 109(5): 1531-1539.
[22]	Centres for Disease Control and Prevention. CDC Issues Revised Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Ebola Virus Exposure[EB/OL].(2014-10-27)[2014-11-20]. http://www.cdc.gov/media/releases/2014/s1027-revised-guidance-monitoring.html.
[23]	Fauci AS. Ebola—Underscoring the global disparities in health care resources[J]. N Engl J Med, 2014, 371(12):1084-1086.

Full-Text